Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.210
+0.020 (1.68%)
At close: Apr 2, 2025, 4:00 PM
1.235
+0.025 (2.07%)
After-hours: Apr 2, 2025, 5:33 PM EDT

BCLI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
7131360145143
Upgrade
Market Cap Growth
-3.18%-3.18%-77.69%-58.70%1.59%47.63%
Upgrade
Enterprise Value
8141557123116
Upgrade
Last Close Price
1.192.274.0924.6060.0067.87
Upgrade
PB Ratio
-0.92-1.67-2.75-19.887.504.03
Upgrade
P/TBV Ratio
----7.514.03
Upgrade
Debt / Equity Ratio
-0.09-0.09-0.26-1.360.260.20
Upgrade
Quick Ratio
0.030.030.170.353.513.76
Upgrade
Current Ratio
0.040.040.240.353.693.85
Upgrade
Return on Equity (ROE)
----297.38%-89.25%-273.75%
Upgrade
Return on Assets (ROA)
-241.99%-241.99%-211.70%-82.24%-38.09%-68.53%
Upgrade
Return on Capital (ROIC)
----121.68%-45.71%-120.66%
Upgrade
Earnings Yield
-162.38%-89.78%-128.57%-40.51%-16.85%-22.27%
Upgrade
FCF Yield
--153.13%-32.29%-18.33%-24.90%
Upgrade
Buyback Yield / Dilution
-74.87%-74.87%-17.99%-0.91%-21.22%-36.25%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q